Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anxiety Disorders in Neurologic Illness.
Davies RD, Gabbert SL, Riggs PD. Davies RD, et al. Curr Treat Options Neurol. 2001 Jul;3(4):333-346. doi: 10.1007/s11940-001-0038-1. Curr Treat Options Neurol. 2001. PMID: 11389804
Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders.
Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D. Riggs PD, et al. Among authors: davies rd. J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):903-14. doi: 10.1016/j.jaac.2011.06.010. Epub 2011 Aug 4. J Am Acad Child Adolesc Psychiatry. 2011. PMID: 21871372 Free PMC article. Clinical Trial.
Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder.
Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC. Winhusen TM, et al. Among authors: davies rd. J Child Adolesc Psychopharmacol. 2011 Oct;21(5):455-63. doi: 10.1089/cap.2011.0014. J Child Adolesc Psychopharmacol. 2011. PMID: 22040190 Free PMC article. Clinical Trial.
Treatment resistance in anxiety disorders.
Davies RD, Dubovsky SL, Gabbert S, Chapman M. Davies RD, et al. Bull Menninger Clin. 2000 Summer;64(3 Suppl A):A22-36. Bull Menninger Clin. 2000. PMID: 11002528 Review.
Substance Use Disorders and Neurologic Illness.
Davies RD, Thurstone C, Woyewodzic K. Davies RD, et al. Curr Treat Options Neurol. 2004 Sep;6(5):421-432. doi: 10.1007/s11940-996-0032-8. Curr Treat Options Neurol. 2004. PMID: 15279762
38 results